Micrornas and uses thereof
View Patent ↗Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
1. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 4277;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a);
(c) a sequence at least 80% identical to (a) or (b); or
(d) the complement of any one of (a)-(c), wherein the complement is identical in length to (a).
2. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 15666;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a);
(c) a sequence at least 80% identical to (a) or (b); or
(d) the complement of any one of (a)-(c), wherein the complement is identical in length to (a).
3. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 15667;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a); or
(c) the complement of (a) or (b), wherein the complement is identical in length to (a).
4. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .
5. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 2 .
6. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 3 .
7. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .
8. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 2 .
9. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the nucleic acid of claim 3 .